Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Inflammation

INDICATION: Cytokine release syndrome (CRS)

Mouse studies suggest down-regulating catecholamines with NPPA or the TYH inhibitor Demser could

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE